Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

NCT01745900 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2012-12-10

No results posted yet for this study

Summary

Comparison of noninvasive glucose measurement performance versus standard invasive reference measurements.

Conditions

  • Insulin Dependent Diabetes
  • Non Insulin Dependent Diabetes
  • Gestational Diabetes

Sponsors & Collaborators

  • InLight Solutions

    collaborator INDUSTRY
  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • Amber Brassfield, RN · Accelovance

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01745900 on ClinicalTrials.gov